Income StatementBalance SheetCash FlowSegments
Ford Motor Company logo

Ford Motor Company Cash Flow Statement

Operating, investing, and financing cash movements

Ford Motor Company generated $21.3B in operating cash flow over the trailing twelve months. After $8.8B in capital expenditures, free cash flow was $12.5B. Free cash flow increased 0.8% year-over-year. Based on the Q4 2025 filing.

Net Cash From Operating (TTM)$21.3BNet Cash From Investing (TTM)-$18.0BNet Cash From Financing (TTM)$232.0MCapital Expenditures (TTM)$8.8BNet Change In Cash (TTM)$3.4B
Latest FilingQ4 2025
Report Date2026-02-11
Market Cap$47.8B
ROE-20.21%

Operating

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Amortization of Investment Discount and Premium$425.0M$425.0M$459.8M$459.8M$459.8M$459.8M
Change in inventories-$6.8M-$6.8M-$134.8M-$134.8M-$134.8M-$134.8M
Other working capital changes$659.0M$89.0M$32.0M$181.0M$210.0M—
Change in Finance Receivables$874.0M$1.6B-$2.4B-$500.0M$322.0M-$2.4B
Deferred income taxes-$535.0M$679.0M-$54.0M$266.0M-$733.0M-$4.0B
Net cash from operating activities$5.5B$3.0B$3.7B$6.3B$7.4B$3.9B
Net income$896.0M$1.8B$473.0M-$29.0M$2.4B-$11.1B
Asset write-downs$0.0$0.0$2.4B$2.4B$2.4B$2.4B
Depreciation$1.8B$1.9B$1.8B$1.9B$2.0B$2.1B
Foreign currency remeasurement (loss) gain on debt-$123.0M—-$38.0M-$24.0M$64.0M—
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax-$56.8M-$56.8M$21.8M$21.8M$21.8M$21.8M
Gain (Loss) on Investments-$17.0M-$17.0M$32.0M$11.0M$20.0M$283.0M
Income Loss From Equity Method Investments Net Of Dividends Or Distributions$92.0M$71.0M$14.0M-$275.0M-$51.0M-$3.3B
Increase (Decrease) in Accounts Payable and Other Operating Liabilities$4.1B—$3.0B$4.3B$3.3B$0.0
Increase (Decrease) in Accounts Receivable and Other Operating Assets$443.0M$451.0M$1.3B$2.2B$177.0M—
Increase Decrease In Inventories And Other Operating Assets$493.0M—$2.7B-$1.2B-$771.0M—
Pension and other postretirement income$488.0M—$94.0M$93.0M$90.0M$785.0M
Provision for Loan, Lease, and Other Losses$116.0M$142.0M$161.0M$162.0M$154.0M$139.0M
Stock-based compensation$129.0M$107.0M$121.0M$154.0M$134.0M$101.0M

Investing

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Capital expenditures$2.0B$2.5B$1.8B$2.1B$2.1B$2.8B
Collections of finance receivables$11.3B$11.3B$11.0B$11.6B$11.8B$11.4B
Payments for (Proceeds from) Derivative Instrument, Investing Activities-$63.0M$94.0M$180.0M-$76.0M$237.0M$102.0M
Payment for (Proceeds from) Other Investing Activity$50.0M$73.0M$45.0M-$225.0M$30.0M—
Payments to Acquire Equity Method Investments$901.0M$123.0M$3.0M$135.0M$304.0M$730.0M
Payment for Acquisition, Loan and Lease, Held-for-Investment$15.4B$14.8B$11.6B$12.8B$15.6B$15.7B
Net cash from investing activities-$5.6B-$6.9B$210.0M-$3.2B-$7.4B-$7.7B
Dividend Received from Consumer Healthcare JV$9.0M$1.4B$1.7B$0.0$1.0M$1.0M

Financing

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Proceeds from issuance of debt$14.6B$13.7B$12.0B$8.5B$16.5B$12.7B
Repayments of debt$10.4B$10.1B$16.2B$8.6B$12.7B$12.8B
Dividends paid$597.0M$596.0M$1.2B$597.0M$597.0M$599.0M
Other, net-$36.0M-$37.0M-$116.0M-$30.0M-$54.0M-$55.0M
Proceeds from (Repayments of) Short-Term Debt-$225.0M—-$564.0M-$546.0M$704.0M$1.1B
Net cash from financing activities$3.3B$3.8B-$6.1B-$1.3B$3.9B—
Repurchases of common stock$32.0M$150.0M$0.0$0.0$0.0$0.0

Free Cash Flow

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Free cash flow$3.5B$530.0M$1.9B$4.2B$5.3B$1.1B

Other

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Effect of exchange rate changes on cash$275.0M-$493.0M$118.0M$365.0M-$41.0M$90.0M
Net increase (decrease) in cash$3.5B-$536.0M-$2.1B$2.2B$3.8B—